Abstract
Introduction

35
In the last decade the antimicrobial resistance (AMR) associated with zoonotic foodborne 36 pathogens of bacterial origin is recognized as a major public health concern. Zoonotic 37 foodborne bacteria are infectious agents which may be transferred from animals to humans Antimicrobial resistance associated with major zoonotic foodborne pathogens (Salmonella,
71
Campylobacter) occurring in food animals can spread to people via food/water consumption 72 and direct animal-human contact. In addition, commensal bacteria (e.g. E. coli, enterococci), 73 can also form a reservoir of resistance genes in environment, farm and food animals (Barton, result in extra healthcare costs and productivity losses of at least EUR 1.5 billion each year.
84
In addition, there is a gap between the burden of infections due to multidrug-resistant bacteria 85 and the development of new, effective antibiotics to tackle the problem. There are numerous 86 studies to highlight the problem related to AMR and to identify the sources and causes for 87 development of this phenomenon, but it is still uncertain how much it can be contributed to 88 the food chain, in particular meat chain. foodborne pathogens and related antimicrobial resistance, including the public health impact.
107
The selection criteria chosen to identify the relevant articles within the scope of this review 108 and the objectives of this paper were as follow: 1) focus on the specific AMR monitoring and 
AMR in Humans
153
The first concerns about antimicrobial resistance in humans were raised in Denmark, in 1994 .
210
Significant increase in the rate of gram-negative microorganisms isolated from humans (Table 3) . reporting, as well as improve the comparability of the data generated among MSs.
257
A comprehensive study of AMR in bacteria isolated from food animals to antimicrobial trimethoprim-sulphonamides (97%). In hens and broilers, the extreme level of resistance in E.
285
coli was confirmed to amoxicillin (98%), ceftiofur (97%), gentamycin (96%), tetracycline
286
(98%), flumequine (97%), enrofloxacin (97%) and trimethoprim-sulphonamides (97%).
287
In Netherlands, the antimicrobial resistance detected in S. Typhimurium was predominantly 288 associated with pigs, but was also found (although less predominant) in cattle and poultry. cephalosporins (critically important antibiotics) which was low in most animal species.
302
Susceptibility testing of enterococci is considered of lesser priority than E. coli and from from faeces and environment is monitored and the epidemiology of this resistance is studied.
323
The majority of isolates (75%) were susceptible to all antibiotics tested (SVARM, 2014).
324
In Norway, the situation regarding antimicrobial resistance to Salmonella spp. in food 325 animals is very good since those animal populations are almost free from Salmonella spp.
326
To maintain this favourable situation, Norway runs an extensive surveillance programme that 327 covers both live animals (cattle, pigs and poultry) and meat samples (NORM-VET, 2013). Campylobacter strains that were resistant to at least one of seven antimicrobials in the panel.
408
The resistance to tetracycline was the highest (82%), followed with doxycycline (77%), 409 erythromycin (54%), nalidixic acid (41%) and ciprofloxacin (35% 
Pre-harvest (on farm)
463
The objective of AMR monitoring is to collect and test for antimicrobial susceptibility of at activities, restaurants and wholesalers.
500
The sampling design is based on a proportionate stratified sampling scheme at the MS level.
501
The samples are allocated proportionally to the size of the human population in the regions 502 M A N U S C R I P T In France, the collection of samples for AMR survey in bacteria isolated from the food chain food and environment. This is an integrated approach based on the `One Health` concept. The caecal samples gathered at slaughter from broilers and from fattening turkeys.
A C C E P T E D
Antimicrobial susceptibility testing
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
27
Susceptibility testing aims to quantify drug potency against specific pathogenic bacteria and
595
to establish what measures can be taken to safely formulate the drug so it is a viable option 596 for therapeutic treatments. It is also used to establish if changes in pathogenic behaviour 597 against already tested drugs is occurring due to microbial resistance. When EUCAST defines 598 a microorganism as "susceptible" this generally means that the microorganism is susceptible 599 to the therapy and that success when this specific antimicrobial agent is used is high. The 600 opposite is defined when the microorganism is resistant to selected antimicrobial agent.
601
When determining the ability of antimicrobials to be successful against a specific pathogen, 
622
Although disk diffusion is the most widely used method for measurement of antimicrobial 623 activity against Salmonella in routine clinical laboratories, since it is inexpensive and 624 relatively easy to perform, the dilution method (where the MIC is determined in mg/L) is a 625 more accurate measurement than disk diffusion; it is considered as the gold standard for AST. determine susceptibility, the purpose is to assimilate drug potency required to inhibit or kill a 641 pathogen within the body, by using pharmacokinetics and pharmacodynamics. 
Epidemiological cut-off values (ECOFFs)
643
Standardised epidemiological cut off values (ECOFFs) are described by the EU Reference an acquired or mutational resistance mechanism to the drug in question).
650
When bacteria are identified as having resistance, the MIC and IZD displays two major sub-651 populations: i) one is a fully susceptible set of isolates, and ii) the other is a fully resistant and test ranges) should be applied. Such approach is also needed to improve the 803 comparability of data generated among EU MSs.
804
The effective risk mitigation strategies to tackle the antimicrobial resistance in the food 
